Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.
Gilles Kaplanski, Denis Bontemps, Pierre Esnault, Valéry Blasco, Julien Carvelli, D. Delarbre, Raphaël Cauchois, Jean-Marie Forel, Laurent Papazian
Topics & Concepts
AnakinraRuxolitinibCoronavirus disease 2019 (COVID-19)Rescue therapyMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineInternal medicineVirologyDiseaseMyelofibrosisBone marrowInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesAutoimmune and Inflammatory Disorders ResearchPhagocytosis and Immune Regulation